PATENT CLAIM ANALYSIS

Application Number: 16336363
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "234200"]

Abstract:
The present invention relates to a class of cyano-substituted-heterocycles of Formula (I) with activity as inhibitors of deubiquitilating enzymes, in particular, ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30), having utility in a variety of therapeutic areas including cancer and conditions involving mitochondrial dysfunction. (I)

Claim (Index 20):
A compound of formula (I): a tautomer thereof, or a pharmaceutically acceptable salt of said compound or tautomer, wherein:\n ring A is a 9-membered bicyclic, heteroaryl or heterocyclyl ring, having 1 to 4 Z atoms each independently selected from nitrogen, oxygen and sulfur, and the remaining Z atoms are carbon; \n ring A is unsubstituted, or substituted with 1 to 6 Q 1 (R 1 ) n  groups, which may be the same or different; and \n X, R a , R b , R c , R d , R e , R f , R g , R h , R i , R j , Q 1 , R 1 , and n, are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 32.0
- Percentile: 99.0
- Lexical Diversity: 1.32558
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16070936', '16080506', '15738900', '15894025', '16078518']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8434660440271498
- 35 USC 102 Novelty (BERT): 0.5616272344475471
- Combined Prediction Score: 0.8152821630691895
- Mean Citation Score: 433.761262
- Max Citation Score: 448.00748
- Similarity Product: 367.6631514985085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test